Latest Articles

Publication Date
GSK’s Jemperli combination recommended by NICE as first-line endometrial cancer treatment - PMLiVE

GSK’s Jemperli combination recommended by NICE as first-line endometrial cancer treatment PMLiVE

Published: March 5, 2024, 8 a.m.
A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis - Nature.com

A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis Nature.com

Published: March 2, 2024, 8 a.m.
Women need better care to avoid endometrial cancer development, study finds - University of Birmingham

Women need better care to avoid endometrial cancer development, study finds University of Birmingham

Published: March 1, 2024, 8 a.m.
Analysis of clinical data of different endometrial pathological types in perimenopausal women with abnormal uterine bleeding - Frontiers

Analysis of clinical data of different endometrial pathological types in perimenopausal women with abnormal uterine bleeding Frontiers

Published: Feb. 29, 2024, 8 a.m.
CLDN6-23-ADC shows promise for ovarian, endometrial tumors - BioWorld Online

CLDN6-23-ADC shows promise for ovarian, endometrial tumors BioWorld Online

Published: Feb. 29, 2024, 8 a.m.
Endocrine disruptors may increase the risk of endometrial cancer - ibsgranada.es

Endocrine disruptors may increase the risk of endometrial cancer ibsgranada.es

Published: Feb. 28, 2024, 8 a.m.
Modeling embryo-endometrial interface recapitulating human embryo implantation - Science

Modeling embryo-endometrial interface recapitulating human embryo implantation Science

Published: Feb. 23, 2024, 8 a.m.
Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients - Nature.com

Loss of EIF4G2 mediates aggressiveness in distinct human endometrial cancer subpopulations with poor survival outcome in patients Nature.com

Published: Feb. 22, 2024, 8 a.m.
FDA Grants Priority Review to Pembrolizumab/Chemo in Endometrial Cancer - Cancer Network

FDA Grants Priority Review to Pembrolizumab/Chemo in Endometrial Cancer Cancer Network

Published: Feb. 20, 2024, 8 a.m.
Pregnancy outcomes in infertile patients with endometrial hyperplasia with or without atypia undergoing in vitro fertilization: the early-follicular long protocol is superior to midluteal long protocol - Frontiers

Pregnancy outcomes in infertile patients with endometrial hyperplasia with or without atypia undergoing in vitro fertilization: the early-follicular long protocol is superior to midluteal long protocol Frontiers

Published: Feb. 19, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!